| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Endocrinology Division (V.K., Y.M., S.F., C.A.F.), Eli Lilly & Co., Lilly Corporate Center, Indianapolis, Indiana 46285; St. Vincent’s Institute of Medical Research (J.M.M.), Victoria 3065, Australia
Address all correspondence and requests for reprints to: Venkatesh Krishnan, Endocrinology Division, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, Indiana 46285. E-mail: Krishnan_Gary{at}lilly.com
A neonatal rat metatarsal organ culture model has been employed to study the anabolic effects of Sonic/Indian hedgehog and BMP-4. In this culture system, a significant increase in endochondral ossification is measured by an increase in length of mineralized bone, after daily treatment for 7 days with Sonic hedgehog protein (Shh-N). Previous evidence indicated that PTH related protein (PTHrP) is a critical target of hedgehog function in endochondral ossification. Using a PTHrP blocking antibody, it is shown that hedgehog mediates this activity via pathways other than through PTHrP. A dose-related increase in endochondral ossification is observed when metatarsals are treated with 25 ng/ml recombinant human bone morphogenetic protein 4 (BMP-4). However, this activity is not evident at higher doses of BMP-4 (200 ng/ml). High doses of BMP-4 resulted in increased expression of noggin messenger RNA and cotreatment of noggin and Shh-N resulted in reversal of the anabolic action of Shh-N. This observation suggests that BMP-4 signaling can influence the Shh-N mediated increase in endochondral ossification. Finally, we show that the Shh-N and BMP-4 mediated increase in endochondral ossification is reversed by treatment with antisense oligonucleotides targeted against Cbfa1. Thus, this report identifies Shh-N as an inducer of endochondral ossification that mediates its effect via BMP-4 and Cbfa1-dependent pathways.
This article has been cited by other articles:
 |
|
 |
|
  A. Mukherjee and P. Rotwein Insulin-Like Growth Factor-Binding Protein-5 Inhibits Osteoblast Differentiation and Skeletal Growth by Blocking Insulin-Like Growth Factor Actions Mol. Endocrinol., May 1, 2008; 22(5): 1238 - 1250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Dwyer, N. Sever, M. Carlson, S. F. Nelson, P. A. Beachy, and F. Parhami Oxysterols Are Novel Activators of the Hedgehog Signaling Pathway in Pluripotent Mesenchymal Cells J. Biol. Chem., March 23, 2007; 282(12): 8959 - 8968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yaar, C. Wu, H.-Y. Park, I. Panova, G. Schutz, and B. A. Gilchrest Bone Morphogenetic Protein-4, a Novel Modulator of Melanogenesis J. Biol. Chem., September 1, 2006; 281(35): 25307 - 25314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. K. Chan, D. Miao, R. Deckelbaum, I. Bolivar, A. Karaplis, and D. Goltzman Parathyroid Hormone-Related Peptide Interacts with Bone Morphogenetic Protein 2 to Increase Osteoblastogenesis and Decrease Adipogenesis in Pluripotent C3H10T1/2 Mesenchymal Cells Endocrinology, December 1, 2003; 144(12): 5511 - 5520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Canalis, A. N. Economides, and E. Gazzerro Bone Morphogenetic Proteins, Their Antagonists, and the Skeleton Endocr. Rev., April 1, 2003; 24(2): 218 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Krishnan, T. L. Moore, Y. L. Ma, L. M. Helvering, C. A. Frolik, K. M. Valasek, P. Ducy, and A. G. Geiser Parathyroid Hormone Bone Anabolic Action Requires Cbfa1/Runx2-Dependent Signaling Mol. Endocrinol., March 1, 2003; 17(3): 423 - 435. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
